Physician

Anthony Joseph Degenhard, D.O.

According to 2025 Medicare claims, Anthony Degenhard, D.O. (NPI: 1790781193) practices nephrology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is KIDNEY & HYPERTENSION CONSULTANTS, INC. (NPI: 1770524696; TIN: 34-1421578) and primary practice location at 44708-6220. Degenhard is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Degenhard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 664 traditional Medicare patients, billed 4,829 HCPCS/CPT codes, and received $315,992 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,945 prescription claims across 300 beneficiaries totaling $122,339 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 66 claims. Open Payments data shows 39 records totaling $813. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $309,738 and ending at $122,339. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	531	7,109	$303,473
2016	552	5,634	$276,453
2017	596	5,011	$295,143
2018	589	5,602	$290,220
2019	596	4,544	$269,515
2020	519	3,642	$256,624
2021	533	3,062	$262,222
2022	468	2,479	$191,781
2023	449	5,311	$277,067
2024	664	4,829	$315,992

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	283	2,707	$309,738
2016	257	2,224	$191,698
2017	244	2,123	$245,547
2018	245	1,849	$146,051
2019	294	2,246	$149,140
2020	313	2,302	$222,569
2021	325	2,324	$181,249
2022	312	1,949	$183,995
2023	329	2,100	$329,620
2024	300	1,945	$122,339

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$370
2017	N/R	49	$1,527
2018	N/R	80	$3,995
2019	N/R	38	$1,075
2020	N/R	68	$3,493
2021	N/R	67	$1,511
2022	N/R	64	$844
2023	N/R	78	$971
2024	N/R	66	$736

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	135	151	$125
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	186	449	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	284	441	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	150	312	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	72	78	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	55	2,190	$40,295
Prosol	Parenteral Amino Acid 20% No.1	45	315	$6,572
Calcitriol	Calcitriol	213	12,694	$4,396
Tolvaptan	Tolvaptan	13	390	$3,084
Potassium Chloride	Potassium Chloride	55	3,284	$2,569

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	22	$251
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$188
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	11	$171
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$119
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	11	$7

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$813	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony Joseph Degenhard, D.O.?

Tedicare shows public-source Medicare data for Anthony Joseph Degenhard, D.O. (NPI 1790781193), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Joseph Degenhard, D.O. have ACO affiliation data?

Anthony Joseph Degenhard, D.O. is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Anthony Joseph Degenhard, D.O.?

Anthony Joseph Degenhard, D.O. is linked to KIDNEY & HYPERTENSION CONSULTANTS, INC. (billing NPI 1770524696) in the available physician profile data.

Does Anthony Joseph Degenhard, D.O. have Open Payments data?

Anthony Joseph Degenhard, D.O. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.